PL

Business Context and Reporting Period

Company: Planet Labs PBC
Filing Type: Form 8-K (Current Report)
Date of Report: June 5, 2026
Event: Entry into a Material Definitive Agreement (Equity Distribution Agreement).

Key Financial Metrics

This filing does not report operational financial metrics such as revenue, profit, cash flow, margins, or debt levels. The primary financial figure disclosed is the authorization for a potential capital raise:

• Maximum Offering Size: Up to $1,500,000,000 of Class A common stock.
• Commission Rate: Up to 2% of the sales price per share for Sales Agents and Forward Sellers.
• Proceeds: Net proceeds will be gross proceeds less commissions and issuance costs; no proceeds are initially received from forward sale agreements.

Material Changes

The material change reported is the execution of an Equity Distribution Agreement with multiple Sales Agents (including Goldman Sachs, Morgan Stanley, and Citigroup) and Forward Purchasers. This agreement establishes an "at-the-market" offering program allowing the Company to sell shares over time. Additionally, the Company filed a shelf registration statement on Form S-3 on June 5, 2026, which became effective automatically.

Guidance, Outlook, and Risks

Management Commentary and Mechanism: The agreement allows for two primary sale methods:

1. At-the-Market Offering: Sales through agents or principals based on market conditions.
2. Range Forward Transactions: Complex forward sale agreements where Forward Purchasers borrow shares to sell (hedging) while the Company agrees to deliver shares later at a price determined by a floor and cap based on volume-weighted average prices.

Risks and Contingencies:

• Termination: The Company or agents may terminate the agreement at any time for any reason.
• Market Conditions: Sales may be suspended if they cannot be effected at or above a designated price. There is no assurance that any shares will be sold.
• Forward Transaction Risks: If Forward Purchasers cannot borrow shares or if stock loan costs exceed a specified amount, the number of shares in a Range Forward Transaction may be reduced to zero.
• Dilution: The issuance of shares will result in dilution to existing shareholders.

Unusual Items: The filing details a complex hedging structure involving "Range Forward Transactions" where the Company may receive prepayments or settlement amounts based on floor prices and forward hedge selling commissions, rather than immediate cash proceeds from the sale of borrowed shares.

Investor Verification Checklist

• Verify the current market price of Planet Labs PBC (PL) to assess the potential dilution impact of a $1.5 billion offering.
• Review the full text of the Equity Distribution Agreement (Exhibit 1.1) for specific floor and cap percentages in Range Forward Transactions.
• Monitor subsequent filings to determine if and when the Company elects to sell shares under this program.
• Check the Company's latest 10-K or 10-Q for current cash position and liquidity needs to understand the urgency of this capital raise.
• Confirm the status of the Form S-3 shelf registration statement on the SEC EDGAR database.